Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies. | Front Immunol | 2022 | 35979372 | PubTator, text mining | PubMed |
| A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression. | Blood Adv | 2022 | 35973197 | PubTator, text mining | PubMed |
| Selecting the optimal BTK inhibitor therapy in CLL: rationale and practical considerations. | Ther Adv Hematol | 2022 | 35966045 | PubTator, text mining | PubMed |
| The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study. | Hematol Oncol | 2022 | 35961859 | PubTator, text mining | PubMed |
| Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL. | Mol Syst Biol | 2022 | 35959629 | PubTator, text mining | PubMed |
| Diverse mutational landscapes in human lymphocytes. | Nature | 2022 | 35948631 | PubTator, text mining | PubMed |
| Successful Retreatment With Venetoclax in a Patient With Chronic Lymphocytic Leukemia. | Hemasphere | 2022 | 35935612 | PubTator, text mining | PubMed |
| Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting. | Hemasphere | 2022 | 35935605 | PubTator, text mining | PubMed |
| Molecular map of chronic lymphocytic leukemia and its impact on outcome. | Nat Genet | 2022 | 35927489 | PubTator, text mining | PubMed |
| Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL. | Blood | 2022 | 35921541 | PubTator, text mining | PubMed |
| Machine Learning Approaches to TCR Repertoire Analysis. | Front Immunol | 2022 | 35911778 | PubTator, text mining | PubMed |
| Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance. | Blood Lymphat Cancer | 2022 | 35911566 | PubTator, text mining | PubMed |
| Richter Transformation: Clinical Manifestations, Evaluation, and Management. | J Adv Pract Oncol | 2022 | 35910504 | PubTator, text mining | PubMed |
| An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia. | J Adv Pract Oncol | 2022 | 35910501 | PubTator, text mining | PubMed |
| Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia. | Front Oncol | 2022 | 35903706 | PubTator, text mining | PubMed |
| Identification of proliferative and non-proliferative subpopulations of leukemic cells in CLL. | Leukemia | 2022 | 35902732 | PubTator, text mining | PubMed |
| Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells. | Nat Immunol | 2022 | 35902638 | PubTator, text mining | PubMed |
| Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages. | Diagnostics (Basel) | 2022 | 35892513 | PubTator, text mining | PubMed |
| Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench. | Cancers (Basel) | 2022 | 35884406 | PubTator, text mining | PubMed |
| Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis. | Front Immunol | 2022 | 35874696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=28